Lexicon Pharmaceuticals, Inc. (LXRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 417.51M |
| Enterprise Value | 445.42M |
| P/E Ratio | -15.23 |
| PEG Ratio | 0.12 |
| Price/Sales Ratio | 24.53 |
| Price/Book Ratio | 5.74 |
| Enterprise/Revenue | 24.97 |
| Enterprise/EBITDA | -19.82 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.47 |
| Operating Margin | -1.31 |
AD
Management Effectiveness
| Return On Assets | -0.24 |
| Return On Equity | -0.4 |
Income Statement
| Revenue | 49.8M |
| Revenue/Share | 0.09 |
| Gross Profit | 49.53M |
| EBITDA | -41.38M |
| Net Income | -50.34M |
| Diluted EPS | -0.14 |
Balance Sheet
| Total Cash | 190.61M |
| Total Cash/Share | 0.44 |
| Total Debt | 59.28M |
| Total Debt/Equity | 0.34 |
| Current Ratio | 13.37 |
| Book Value Per Share | 0.4 |
Price History
| 52-Week Change | 99.13 |
| 52-Week High | 2.68 |
| 52-Week Low | 1.03 |
| Moving Average 50 Days | 2.31 |
| Moving Average 200 Days | 1.76 |
Statistics
| Average Volume | 3.29M |
| Shares Outstanding | 444.2M |
| % Held by Institutions | 91.58 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | May 21, 2015 |
AD
